InvestorsHub Logo
Followers 43
Posts 4894
Boards Moderated 0
Alias Born 04/30/2005

Re: BAR123 post# 409676

Monday, 04/03/2023 11:24:23 AM

Monday, April 03, 2023 11:24:23 AM

Post# of 462976
NO. You're way off base.

Once they commercialize A2-73 for Rett, they will be generating at least $40 - $50 Million/year in net revenue...assuming they treat 50% of the Rett patients in the U.S. alone.

See my post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171604618

My opinion. Do not use my comments to buy or sell shares of AVXL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News